The Digital Neuro Biomarkers Market was valued at USD 538.96 million in 2023 and is projected to rea
The market for digital neuro biomarkers is growing exponentially as a result of increasing neurological disorders, advancements in technology, and the growing demand for personalized healthcare solutions. These are essentially used for the diagnosis, monitoring, and tracking of the progression of various neurological conditions such as Parkinson\'s disease, Alzheimer\'s disease, multiple sclerosis, and epilepsy. Furthermore, real-time data as well as deeper insights into a patient\'s health condition are fuelling the adoption of digital neuro biomarkers across health care settings.